Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System
Post Market Clinical Follow-Up Study of the Zimmer Stafit Acetabular System. A Multicenter, Prospective, Non-controlled Study
Sponsor: Zimmer Biomet
Terminated
Stafit Acetabular System not CE marked anymore
Other terminated trials from Zimmer Biomet
Other Avascular Necrosis of Hip trials with similar outcome
Listed as NCT04079114, this observational or N/A phase trial focuses on Avascular Necrosis of Hip and Dislocated Hip and remains terminated or withdrawn. Sponsored by Zimmer Biomet, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Jul 2020 — Jan 2021 [monthly]
Terminated
▶ Show 1 earlier version
-
Oct 2019 — Jul 2020 [monthly]
Terminated
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.